PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsCommentWe need progress in French ART law

BioNews

We need progress in French ART law

Published 26 February 2018 posted in Comment and appears in BioNews 938

Author

Catherine Rongieres

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.

The first law on Assisted Reproductive Technology (ART) was passed in France in 1994 as part of the so-called 'bioethics legislation', which followed other European countries' legislation, such as the UK's 1990 Human Fertilisation and Embryology act. Fran

The first law on Assisted Reproductive Technology (ART) was passed in France in 1994 as part of the so-called 'bioethics legislation' that followed other European countries' legislation, such as the UK's 1990 Human Fertilisation and Embryology act. France's law which placed much tighter constraints on individuals access to ARTs than the UK.

More European countries followed suit. Germany already possessed the strictest and the most binding legislation in the world regarding ART, with a few recent legal challenges notably on PGD (preimplantation genetic diagnosis). Conversely, Spain, still traumatised by the interference of the dictator Francisco Franco into the private life of citizens, considered ART a matter for the individual, resulting in a relatively non-restrictive 2006 law.

For a long time, Belgium had no legal framework for ART excepting a 2003 law relating to research on in-vitro embryos. Thus, apart from some recommendations relating to the age either of gamete donors, or of the recipient woman, and the prohibition of certain eugenic or commercial practices, there was no other limit or condition. When legislation was brought in, the goal is was to clarify rather than restrict practices: to set the procedures for a more uniform ART, increasing transparency and protecting the patients by reducing multiple embryo transfers. There is no legal limitation for the use of ART as the centres develop their own access criteria.

Thus the law from our neighbouring countries allow for quick and easy access to any new technology.

The French bioethics law of 1994 was revised in 2004 and 2011, as the intention was always to be able to modify it in the face of evolution of practices, and also of opinion and societal changes. In any case, this law was attractive because of the reflection it induced. However, contrary to common law, anything that is not explicitly authorised in this law is forbidden. Thus, any new technology or societal change which had not been anticipated is therefore impossible to access until the next revision.

Furthermore, although these revisions were planned every five years, they took place instead every seven years, and the publication of the necessary administrative permission (known as decrees of application) was sometimes delayed further. For example, while the law authorising women without children to donate eggs was passed in 2011, the necessary decrees were issued only in 2015.

This situation has led to our patients leaving for nearby countries (such as Spain, Belgium and England) to access what is forbidden to them in France. The French law, which claim to protect against commercial, eugenic or other abuses, does not fulfil their aims and undermines the principles on which the French pride themselves. Equitable access to healthcare instead becomes a two-tier system, where those who have the financial resources to go abroad can avail themselves of the techniques forbidden at home.

So yes, the stakes in this new revision of the law are major.

'What kind of world do we want for tomorrow?' It is a question that opened one of the 'états généraux' (or public discussions) on bioethics on 18 January. Such public meetings will continue to be held over six months and inform the new bioethics law, which will include ART access, expected at the end of the year.

The National Advisory Board of Ethics (CCNE) will collect opinions through their website and organise about 60 debates across France open to the public, and stakeholders such as patient groups, professional and academic societies and religious organisations. They will also consult experts from ethics committees of the main research institutes, and the regional education authorities.

It is not acceptable to integrate new technologies only when they have been validated by our neighbours. We shall not recover from the delay in some techniques which today are forbidden in France, such as [PGS (preimplantation genetic screening)], research on embryos or gene therapy. The expertise acquired, the spirit of innovation and criticism that develops whilst enacting a new practice is not transmissible, so we continue to lag behind.

One may well wonder whether the law should rule on any technique and in detail. For example, to be able to use the technique of freezing by vitrification, it was necessary to wait for the revision of the law in 2011. The efficiency of this technique was demonstrated in numerous scientific articles and it was adopted by our international counterparts. As soon as we were able to use it, our results very clearly improved.

But societal changes are also in question. Currently same-sex couples and single women may not access ART. Other forbidden practices include: surrogacy, egg freezing for non-medical reasons (except non-mothers who may preserve five oocytes for themselves when donating), double donation (where both eggs and sperm come from donors) and posthumous embryo transfer to a woman after her husband's death. Donor-conceived offspring have no right to know their genetic origins.

In June 2017, the CCNE recommended against widening access to egg freezing. The arguments put forward are of medical rather than ethical nature: stressing the dangerousness of the stimulation treatments and oocyte retrieval, as well as the lack of certainty of success. But if the CCNE considers the treatments of ART in this light, it should not only prohibit IVF in general but oocyte donation in particular that uses 'dangerous' treatments on women trying to help other women. This argument is totally inconsistent.

It is fundamental that ART professionals, as well as sociologists and lawyers concerned by these questions – as well as the concerned population – mobilise to bring back the debates to the concept of the individual's autonomy. This should be possible with an open and flexible law, which can still forbid eugenic or commercial practices and set limits to avoid dangerous practices. It should also enable access and appropriate research, but not get lost into the details which need purely a scientific peer review. I am afraid that France is not ready for it: we are still too paternalistic.

Related Articles

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
14 June 2019 • 1 minute read

France considers allowing IVF for single and lesbian women

by Dr Yvonne Collins

France plans to lift a ban preventing single women and lesbian couples from accessing IVF and other fertility treatments, announced Prime Minister Édouard Philippe last week...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
28 September 2018 • 2 minutes read

French ethics body backs IVF for single and lesbian women

by Isobel Steer

France's national consultative committee on bioethics has said that single women and gay women should be able to access IVF and other assisted reproductive technologies...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
27 April 2018 • 2 minutes read

Malta prepares to overhaul laws on surrogacy, embryo freezing and IVF

by Jen Willows

The strict laws on assisted reproduction in Malta are set to be liberalised in a bill put forward in Parliament this month, although embryo destruction will remain illegal...

Image by Dr Christina Weis. © Christina Weis
Image by Dr Christina Weis. © Christina Weis
News
16 March 2018 • 1 minute read

Non-cohabiting married couple ruled legal parents in surrogacy case

by Dr Mary Yarwood

A UK man and woman in a platonic marriage have been granted a joint parenting order for their child, born via surrogate...

Image by Dr Christina Weis. © Christina Weis
Image by Dr Christina Weis. © Christina Weis
Comment
9 January 2018 • 3 minutes read

Surrogacy law reform for single people brings children out of legal limbo

by Adem Muzaffer and 2 others

In May 2016, the President of the Family Division, Sir James Munby, declared that certain provisions of UK surrogacy law were incompatible with a father and child’s human rights...

Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family (from Greek and Roman mythology) entwined in coils of DNA.
Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family entwined in coils of DNA (based on the figure of Laocoön from Greek and Roman mythology).
News
8 January 2018 • 1 minute read

German court rules that trans woman cannot be child's mother

by Dr Lanay Griessner

Germany's Federal Court of Justice has ruled that the a trans woman must be registered as her child's legal father and not its mother.

Image by Dr Christina Weis. © Christina Weis
Image by Dr Christina Weis. © Christina Weis
News
20 November 2017 • 2 minutes read

UK waits for law reform after genetic mother ineligible for legal parenthood

by Seán Byrne

A woman has been denied legal parenthood of her surrogate-born child because she is single, despite being the genetic mother...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« From here to paternity: older fathers and sperm donation

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
25 July 2022 • 4 minutes read

Was the Women's Health Strategy worth the wait?

25 July 2022 • 5 minutes read

200 Years of Mendel: From Peas to Personalised Medicine

18 July 2022 • 5 minutes read

The birth of genetics: celebrating 200 years of Mendel

15 July 2022 • 2 minutes read

FILM: Prioritising Patient Safety – How to Minimise Risk in Fertility Treatment

11 July 2022 • 6 minutes read

Dutch Embryos Act under revision

8 August 2022 • 4 minutes read

Citizenship and same-sex parents – about time, Sweden!

8 August 2022 • 2 minutes read

FILM: 200 Years of Mendel – From Peas to Personalised Medicine

1 August 2022 • 4 minutes read

Women's Health Strategy plans reflect rising needs of same-sex female couples

25 July 2022 • 4 minutes read

Was the Women's Health Strategy worth the wait?

25 July 2022 • 4 minutes read

Why the UK should extend the 14-day rule to 28 days

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856